Logo image of USPH

U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:USPH - US90337L1089 - Common Stock

81 USD
+0.76 (+0.95%)
Last: 12/26/2025, 8:20:02 PM
81 USD
0 (0%)
After Hours: 12/26/2025, 8:20:02 PM
Fundamental Rating

5

USPH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. USPH has only an average score on both its financial health and profitability. USPH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year USPH was profitable.
In the past year USPH had a positive cash flow from operations.
USPH had positive earnings in each of the past 5 years.
In the past 5 years USPH always reported a positive cash flow from operatings.
USPH Yearly Net Income VS EBIT VS OCF VS FCFUSPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

USPH has a Return On Assets of 3.01%. This is in the better half of the industry: USPH outperforms 63.73% of its industry peers.
The Return On Equity of USPH (7.15%) is better than 65.69% of its industry peers.
The Return On Invested Capital of USPH (6.11%) is better than 62.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for USPH is below the industry average of 9.61%.
The last Return On Invested Capital (6.11%) for USPH is above the 3 year average (5.78%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.01%
ROE 7.15%
ROIC 6.11%
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
USPH Yearly ROA, ROE, ROICUSPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

USPH's Profit Margin of 4.75% is fine compared to the rest of the industry. USPH outperforms 78.43% of its industry peers.
USPH's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.52%, USPH belongs to the top of the industry, outperforming 81.37% of the companies in the same industry.
In the last couple of years the Operating Margin of USPH has declined.
USPH's Gross Margin of 18.80% is on the low side compared to the rest of the industry. USPH is outperformed by 63.73% of its industry peers.
USPH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.52%
PM (TTM) 4.75%
GM 18.8%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
USPH Yearly Profit, Operating, Gross MarginsUSPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

USPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for USPH has been increased compared to 1 year ago.
The number of shares outstanding for USPH has been increased compared to 5 years ago.
USPH has a better debt/assets ratio than last year.
USPH Yearly Shares OutstandingUSPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
USPH Yearly Total Debt VS Total AssetsUSPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.23 indicates that USPH is not a great score, but indicates only limited risk for bankruptcy at the moment.
USPH has a Altman-Z score (2.23) which is in line with its industry peers.
The Debt to FCF ratio of USPH is 2.82, which is a good value as it means it would take USPH, 2.82 years of fcf income to pay off all of its debts.
USPH has a Debt to FCF ratio of 2.82. This is in the better half of the industry: USPH outperforms 74.51% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that USPH is not too dependend on debt financing.
USPH has a better Debt to Equity ratio (0.30) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.82
Altman-Z 2.23
ROIC/WACC0.7
WACC8.7%
USPH Yearly LT Debt VS Equity VS FCFUSPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

USPH has a Current Ratio of 1.20. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
USPH has a Current ratio (1.20) which is comparable to the rest of the industry.
A Quick Ratio of 1.20 indicates that USPH should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.20, USPH perfoms like the industry average, outperforming 49.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
USPH Yearly Current Assets VS Current LiabilitesUSPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

USPH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.17%.
USPH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.76% yearly.
The Revenue has grown by 17.50% in the past year. This is quite good.
The Revenue has been growing slightly by 6.85% on average over the past years.
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%

3.2 Future

USPH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.49% yearly.
USPH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.56% yearly.
EPS Next Y3.85%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue Next Year16.97%
Revenue Next 2Y11.52%
Revenue Next 3Y9.56%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USPH Yearly Revenue VS EstimatesUSPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
USPH Yearly EPS VS EstimatesUSPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.15, the valuation of USPH can be described as expensive.
USPH's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.57, USPH is valued at the same level.
Based on the Price/Forward Earnings ratio of 26.59, the valuation of USPH can be described as expensive.
USPH's Price/Forward Earnings is on the same level as the industry average.
USPH's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.04.
Industry RankSector Rank
PE 31.15
Fwd PE 26.59
USPH Price Earnings VS Forward Price EarningsUSPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USPH indicates a somewhat cheap valuation: USPH is cheaper than 65.69% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of USPH indicates a somewhat cheap valuation: USPH is cheaper than 63.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.64
EV/EBITDA 12.17
USPH Per share dataUSPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
USPH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)8.1
PEG (5Y)N/A
EPS Next 2Y8.66%
EPS Next 3Y8.49%

5

5. Dividend

5.1 Amount

USPH has a Yearly Dividend Yield of 2.29%.
Compared to an average industry Dividend Yield of 0.58, USPH pays a better dividend. On top of this USPH pays more dividend than 94.12% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.88, USPH pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.29%

5.2 History

On average, the dividend of USPH grows each year by 9.09%, which is quite nice.
USPH has been paying a dividend for at least 10 years, so it has a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
USPH Yearly Dividends per shareUSPH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

USPH pays out 75.41% of its income as dividend. This is not a sustainable payout ratio.
The dividend of USPH is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP75.41%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
USPH Yearly Income VS Free CF VS DividendUSPH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
USPH Dividend Payout.USPH Dividend Payout, showing the Payout Ratio.USPH Dividend Payout.PayoutRetained Earnings

U.S. PHYSICAL THERAPY INC

NYSE:USPH (12/26/2025, 8:20:02 PM)

After market: 81 0 (0%)

81

+0.76 (+0.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners108.19%
Inst Owner Change5.17%
Ins Owners1.87%
Ins Owner Change-1.06%
Market Cap1.23B
Revenue(TTM)758.71M
Net Income(TTM)36.02M
Analysts84.62
Price Target107.27 (32.43%)
Short Float %5.12%
Short Ratio4.35
Dividend
Industry RankSector Rank
Dividend Yield 2.29%
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP75.41%
Div Incr Years4
Div Non Decr Years4
Ex-Date11-17 2025-11-17 (0.45)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.82%
Min EPS beat(2)-3.42%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.36%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.56%
EPS beat(12)4
Avg EPS beat(12)-0.7%
EPS beat(16)7
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)2.04%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-0.36%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)-0.02%
PT rev (1m)-0.97%
PT rev (3m)-0.97%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)-2.91%
EPS NY rev (1m)-5.06%
EPS NY rev (3m)-0.13%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 31.15
Fwd PE 26.59
P/S 1.62
P/FCF 21.64
P/OCF 17.71
P/B 2.44
P/tB N/A
EV/EBITDA 12.17
EPS(TTM)2.6
EY3.21%
EPS(NY)3.05
Fwd EY3.76%
FCF(TTM)3.74
FCFY4.62%
OCF(TTM)4.57
OCFY5.65%
SpS49.92
BVpS33.13
TBVpS-23.9
PEG (NY)8.1
PEG (5Y)N/A
Graham Number44.02
Profitability
Industry RankSector Rank
ROA 3.01%
ROE 7.15%
ROCE 8.08%
ROIC 6.11%
ROICexc 6.29%
ROICexgc 36.03%
OM 11.52%
PM (TTM) 4.75%
GM 18.8%
FCFM 7.5%
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexgc growth 3Y-11.04%
ROICexgc growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.82
Debt/EBITDA 1.37
Cap/Depr 53.9%
Cap/Sales 1.67%
Interest Coverage 9.84
Cash Conversion 62.74%
Profit Quality 157.98%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 2.23
F-Score6
WACC8.7%
ROIC/WACC0.7
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
EPS Next Y3.85%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
Revenue Next Year16.97%
Revenue Next 2Y11.52%
Revenue Next 3Y9.56%
Revenue Next 5YN/A
EBIT growth 1Y26.14%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year40.26%
EBIT Next 3Y18.34%
EBIT Next 5YN/A
FCF growth 1Y-11.66%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y-4.01%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%

U.S. PHYSICAL THERAPY INC / USPH FAQ

What is the ChartMill fundamental rating of U.S. PHYSICAL THERAPY INC (USPH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to USPH.


Can you provide the valuation status for U.S. PHYSICAL THERAPY INC?

ChartMill assigns a valuation rating of 3 / 10 to U.S. PHYSICAL THERAPY INC (USPH). This can be considered as Overvalued.


What is the profitability of USPH stock?

U.S. PHYSICAL THERAPY INC (USPH) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for USPH stock?

The Earnings per Share (EPS) of U.S. PHYSICAL THERAPY INC (USPH) is expected to grow by 3.85% in the next year.


Can you provide the dividend sustainability for USPH stock?

The dividend rating of U.S. PHYSICAL THERAPY INC (USPH) is 5 / 10 and the dividend payout ratio is 75.41%.